Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 4:05 PM View:  | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 01-Apr-24 | Private Sale (Planned) | 250 | $964.73 | $241,182.00 | (2%) 13.59K to 13.34K | |
| 03-Apr-24 4:06 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 01-Apr-24 | Private Sale (Planned) | 100 | $962.53 | $96,253.20 | (< 1%) 18.28K to 18.18K | |
| 15-Mar-24 4:01 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 14-Mar-24 | Planned Option Sale | 5,783 | $956.47 | $5,531,290.00 | (10%) 58.4K to 52.62K | |
| 15-Mar-24 4:01 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 13-Mar-24 | Payment of Exercise | 14,217 | $971.82 | $13,816,400.00 | (20%) 72.62K to 58.4K | |
| 15-Mar-24 4:01 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 13-Mar-24 | Option Exercise | 20,000 | $399.66 | $7,993,200.00 | 38% 52.62K to 72.62K | |
| 05-Mar-24 4:01 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 01-Mar-24 | Private Sale (Planned) | 358 | $967.50 | $346,365.00 | (3%) 13.95K to 13.59K | |
| 05-Mar-24 4:01 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 01-Mar-24 | Private Sale (Planned) | 100 | $982.05 | $98,205.40 | (< 1%) 18.38K to 18.28K | |
| 28-Feb-24 4:04 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 26-Feb-24 | Option Sale | 1,000 | $992.50 | $992,500.00 | (3%) 29.5K to 28.5K | |
| 28-Feb-24 4:04 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 26-Feb-24 | Option Exercise | 1,000 | $413.33 | $413,330.00 | 4% 28.5K to 29.5K | |
| 28-Feb-24 4:04 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 26-Feb-24 | Gift | 1,020 | -- | -- | (2%) 62.46K to 61.44K | |
| 28-Feb-24 4:04 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 26-Feb-24 | Private Sale | 1,000 | $990.00 | $990,000.00 | (2%) 41.27K to 40.27K | |
| 26-Feb-24 4:07 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 26-Feb-24 | Option Sale | 854 | $979.25 | $836,280.00 | (38%) 2.24K to 1.38K | |
| 26-Feb-24 4:07 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 26-Feb-24 | Option Exercise | 854 | $391.92 | $334,700.00 | 62% 1.38K to 2.24K | |
| 26-Feb-24 4:07 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 23-Feb-24 | Option Exercise | 500 | $413.33 | $206,665.00 | 2% 28.5K to 29.0K | |
| 26-Feb-24 4:07 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 23-Feb-24 | Option Sale | 500 | $985.00 | $492,500.00 | (2%) 29.0K to 28.5K | |
| 26-Feb-24 4:07 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 22-Feb-24 | Private Sale | 1,000 | $967.65 | $967,650.00 | (2%) 42.27K to 41.27K | |
| 26-Feb-24 4:07 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 22-Feb-24 | Option Sale | 3,000 | $965.00 | $2,895,000.00 | (10%) 31.5K to 28.5K | |
| 26-Feb-24 4:07 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 22-Feb-24 | Option Exercise | 3,000 | $413.33 | $1,239,990.00 | 11% 28.5K to 31.5K | |
| 20-Feb-24 4:03 PM View: | Yancopoulos George Bd. Co-Chair, President & CSO Director | Regeneron Pharmaceuticals I... (REGN) | 15-Feb-24 | Payment of Exercise | 123,601 | $953.83 | $117,894,000.00 | (9%) 1.39M to 1.27M | |
| 20-Feb-24 4:03 PM View: | Yancopoulos George Bd. Co-Chair, President & CSO Director | Regeneron Pharmaceuticals I... (REGN) | 15-Feb-24 | Option Exercise | 172,723 | $399.66 | $69,030,496.00 | 14% 1.22M to 1.39M | |
| 16-Feb-24 4:15 PM View: | van Plew Daniel P EVP & General Mgr, Industrial | Regeneron Pharmaceuticals I... (REGN) | 14-Feb-24 | Private Sale | 10,434 | $942.28 | $9,831,730.00 | (24%) 44.27K to 33.84K | |
| 13-Feb-24 4:04 PM View: | van Plew Daniel P EVP & General Mgr, Industrial | Regeneron Pharmaceuticals I... (REGN) | 09-Feb-24 | Payment of Exercise | 24,941 | $951.68 | $23,735,800.00 | (36%) 69.21K to 44.27K | |
| 12-Feb-24 4:02 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 09-Feb-24 | Option Sale | 500 | $955.00 | $477,500.00 | (2%) 29.0K to 28.5K | |
| 12-Feb-24 4:02 PM View: | Fenimore Christopher R. SVP Finance & CFO | Regeneron Pharmaceuticals I... (REGN) | 09-Feb-24 | Private Sale | 4,919 | $953.31 | $4,689,320.00 | (17%) 29.35K to 24.43K | |
| 13-Feb-24 4:04 PM View: | van Plew Daniel P EVP & General Mgr, Industrial | Regeneron Pharmaceuticals I... (REGN) | 09-Feb-24 | Option Exercise | 35,375 | $378.30 | $13,382,500.00 | 105% 33.84K to 69.21K | |
| 12-Feb-24 4:02 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 09-Feb-24 | Option Exercise | 500 | $413.33 | $206,665.00 | 2% 28.5K to 29.0K | |
| 12-Feb-24 4:02 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 08-Feb-24 | Option Exercise | 500 | $413.33 | $206,665.00 | 2% 28.5K to 29.0K | |
| 12-Feb-24 4:02 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 08-Feb-24 | Option Sale | 500 | $945.00 | $472,500.00 | (2%) 29.0K to 28.5K | |
| 08-Feb-24 4:02 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 07-Feb-24 | Private Sale | 8,037 | $950.35 | $7,637,950.00 | (11%) 70.5K to 62.46K | |
| 09-Feb-24 4:12 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 07-Feb-24 | Private Sale | 1,000 | $950.00 | $950,000.00 | (2%) 43.27K to 42.27K | |
| 06-Feb-24 4:08 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 05-Feb-24 | Private Sale | 1,000 | $934.71 | $934,710.00 | (7%) 14.95K to 13.95K | |
| 06-Feb-24 4:08 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 02-Feb-24 | Option Exercise | 400 | $378.98 | $151,592.00 | 2% 23.84K to 24.24K | |
| 06-Feb-24 4:08 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 02-Feb-24 | Payment of Exercise | 22,713 | $956.65 | $21,728,400.00 | (24%) 93.21K to 70.5K | |
| 06-Feb-24 4:08 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 02-Feb-24 | Payment of Exercise | 281 | $956.65 | $268,819.00 | (1%) 24.24K to 23.96K | |
| 06-Feb-24 4:08 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 02-Feb-24 | Option Exercise | 30,750 | $399.66 | $12,289,500.00 | 49% 62.46K to 93.21K | |
| 05-Feb-24 4:05 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 01-Feb-24 | Private Sale (Planned) | 100 | $954.22 | $95,422.20 | (< 1%) 18.48K to 18.38K | |
| 02-Feb-24 4:02 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 01-Feb-24 | Private Sale (Planned) | 273 | $945.61 | $258,152.00 | (2%) 15.22K to 14.95K | |
| 02-Feb-24 4:02 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 31-Jan-24 | Payment of Exercise | 282 | $953.42 | $268,864.00 | (1%) 24.13K to 23.84K | |
| 02-Feb-24 4:02 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 31-Jan-24 | Option Exercise | 400 | $378.98 | $151,592.00 | 2% 23.73K to 24.13K | |
| 31-Jan-24 4:52 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 30-Jan-24 | Planned Option Sale | 827 | $959.00 | $793,093.00 | (37%) 2.21K to 1.38K | |
| 31-Jan-24 4:52 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 30-Jan-24 | Option Exercise | 827 | $380.95 | $315,046.00 | 60% 1.38K to 2.21K | |
| 25-Jan-24 4:17 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 24-Jan-24 | Payment of Exercise | 352 | $951.26 | $334,844.00 | (1%) 24.08K to 23.73K | |
| 25-Jan-24 4:17 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 24-Jan-24 | Option Exercise | 500 | $378.98 | $189,490.00 | 2% 23.58K to 24.08K | |
| 25-Jan-24 4:17 PM View: | Fenimore Christopher R. SVP Controller | Regeneron Pharmaceuticals I... (REGN) | 23-Jan-24 | Option Exercise | 10,000 | $477.67 | $4,776,650.00 | 37% 26.92K to 36.92K | |
| 25-Jan-24 4:17 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 23-Jan-24 | Option Exercise | 1,100 | $378.98 | $416,878.00 | 5% 23.25K to 24.35K | |
| 25-Jan-24 4:18 PM View: | Goldstein Joseph L Director | Regeneron Pharmaceuticals I... (REGN) | 23-Jan-24 | Option Exercise | 2,707 | $625.60 | $1,693,500.00 | 42% 6.38K to 9.09K | (< 1%) |
| 25-Jan-24 4:18 PM View: | Goldstein Joseph L Director | Regeneron Pharmaceuticals I... (REGN) | 23-Jan-24 | Planned Private Option Sale | 2,707 | $950.00 | $2,571,650.00 | (30%) 9.09K to 6.38K | |
| 25-Jan-24 4:17 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 23-Jan-24 | Payment of Exercise | 776 | $948.50 | $736,036.00 | (3%) 24.35K to 23.58K | |
| 25-Jan-24 4:17 PM View: | Fenimore Christopher R. SVP Controller | Regeneron Pharmaceuticals I... (REGN) | 23-Jan-24 | Payment of Exercise | 7,569 | $948.50 | $7,179,200.00 | (21%) 36.92K to 29.35K | |
| 18-Jan-24 4:02 PM View: | Landry Robert E EVP Finance CFO | Regeneron Pharmaceuticals I... (REGN) | 17-Jan-24 | Option Exercise | 500 | $378.98 | $189,490.00 | 2% 23.11K to 23.61K |
